FindTrial
Sign In

Effect of Hijama therapy on blood parameters in joint pain patients

Assessment of changes in blood components before and after Hijama for Wajaul Mafasil - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/03/105766
Enrollment
40
Registered
2026-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M130- Polyarthritis, unspecified

Interventions

Intervention1: Nil: Hijama will be performed on patients diagnosed with Wajaul Mafasil. Comparator is Nill Intervention2: NIL: NIL Intervention3: NIL: NIL

Sponsors

Dr MD Zafar Iqbal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who willing to go through necessary blood test before and after hijama session. Clinically diagnosed and stable patients. Patients agreed to avoid medication for the same disease till last hiajama session

Exclusion criteria

Exclusion criteria: Unstable, bed ridden and mentally retard patients. patients having blood disorder like haemophilia, sickle cell anaemia, thalassemia etc.Diabetic patients ( with healing disorder). Traumatic patients( fracture and joint dislocation). patients having malignancy. Patients having local wounds and acute infection. pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
To assess the changes in hematological and biochemical parameters( like CBC,CRP,ESR,S.Uric acid, RA factor, ASO titer etc.) before and after hijama therapy in patients of wajaul mafasilTimepoint: 21-30 days—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Md Tanwir Alam

Government Tibbi College and Hospital Kadam Kuan Patna

msakhtar10@gmail.com7277666356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026